Company / FCF Margin
IGC Pharma, Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-386.1%
FY2025
5-year range
-1939.0% / -320.9%
FY2021-FY2025
Trend
+52.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 10 years, ranging from -1939.0% in FY2023 to -4.4% in FY2017.
Based on SEC 10-K filings.
-386.1% in FY2025 with a 5-year CAGR of -320.7%.
Improved from -1939.0% to -386.1% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +980.3pp
- 5-Year Change
- -320.7pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 52.2% year-over-year.
- Peak fcf margin was recorded in FY2017.
- Lowest fcf margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -386.1% | +52.2% |
| FY2024 | -807.6% | +58.4% |
| FY2023 | -1939.0% | -41.9% |
| FY2022 | -1366.4% | -325.8% |
| FY2021 | -320.9% | -390.8% |
| FY2020 | -65.4% | +30.6% |
| FY2019 | -94.3% | +64.4% |
| FY2018 | -264.8% | -5918.0% |
| FY2017 | -4.4% | +87.3% |
| FY2016 | -34.6% | +55.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026